Indefinite Delivery Contract SPE2DR25D2010

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This single-award IDC will serve as the primary vehicle for the DLA to procure brand-name and generic drugs, specialty medications, vaccines, syringes, vials, and other critical medical commodities across multiple therapeutic areas. The contract has a 30-month base period with three 30-month option periods, running through December 2036.

This IDC is part of the DLA's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which will establish multiple regional prime vendor contracts to support the healthcare needs of the Department of Defense, U.S. Coast Guard, and other designated government agencies. The contract is expected to have a total estimated value of $30.3 billion and will be awarded through a lowest-price technically acceptable (LPTA) process, with the potential use of reverse auctions to determine final distribution fees. The procurement will be unrestricted, with the intention to award at least three different contractors to ensure resiliency in the pharmaceutical supply chain.